YUMAB GmbH
PrivateLast Round
Grant
Jan 27, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
YUMAB GmbH is a biotechnology company that provides contract research, technologies, and R&D services for the development of fully human therapeutic antibodies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
YUMAB GmbH Comparables
Compare YUMAB GmbH with similar companies based on industry and business-model similarity.
YUMAB GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 27, 2025 | ||||
| Grant | Oct 17, 2023 | ||||
| Grant | Jul 19, 2023 |
YUMAB GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bundesministerium für Bildung und Forschung | Grant |
| NBank | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 325% MoM, reaching 204.
- Jul 3, 2025
Monthly visitors grew 308% MoM, reaching 4.9K.
YUMAB GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about YUMAB GmbH's valuation, stock price, and market status.
Is YUMAB GmbH a public or private company?
YUMAB GmbH is a private company.
What is the current stock price of YUMAB GmbH?
YUMAB GmbH is a private company with no public stock price. No recent secondary market data is available.
How much is YUMAB GmbH worth (valuation)?
Valuation information for YUMAB GmbH is not publicly available.
Can I buy YUMAB GmbH stock?
YUMAB GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was YUMAB GmbH's last funding round?
YUMAB GmbH's most recent funding round was Grant on January 27, 2025.
Who are the main investors in YUMAB GmbH?
Key investors in YUMAB GmbH include Bundesministerium für Bildung und Forschung, NBank.
Will YUMAB GmbH IPO soon?
No public IPO plans have been announced for YUMAB GmbH.
How can I track YUMAB GmbH secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor YUMAB GmbH's secondary market activity and sign up for updates.